Role of insulin-like growth factor binding protein-2 and its limited proteolysis in neuroblastoma cell proliferation: Modulation by transforming growth factor-β and retinoic acid

Endocrinology

Volumn 138, Issue 2, 1997, Pages 683-690

  Menouny, Mouna ^a   Binoux, Michel ^a   Babajko, Sylvie ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID; SOMATOMEDIN BINDING PROTEIN 2; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CELL STIMULATION; HUMAN; HUMAN CELL; MITOGENESIS; NERVE CELL GROWTH; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM;

EID: 0031046959     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.2.4919     Document Type: Article

References (44)

1. Sara VR 1992 The role of insulin-like growth factors in the nervous system. In: Schoffield PN (ed) Insulin-Like Growth Factors. Structure and Biological Functions. Oxford University Press, pp 80-109
2. Depablo F, Delarossa EJ 1995 The developing central nervous system: a scenario for the action of proinsulin, insulin and insulin-like growth factors. Trends Neurosci 18:143-150
3. Ishii DN, Wang C, Li Yi 1991 Second messengers mediating gene expression essential to neurite formation directed by insulin-like growth factors. In: Mohan K, LeRoith D (eds) Molecular Biology and Physiology of Insulin-Like Growth Factors. Plenum Press, pp 361-378
4. El-Badry O, Romanus JA, Helman LJ, Cooper MJ, Rechler MM, Israel MA 1989 Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest 84:829-839
5. El-Badry OM, Helman LJ, Chatten J, Steinberg SM, Evans AE, Israel MA 1991 Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest 87:648-657
6. Meghani AA, Martin DM, Singleton JR, Feldman EL 1993 Effects of serum and insulin-like growth factors on human neuroblastoma cell growth. Regul Pept 48:217-224
7. Banskota NK, Taub R, Zellner K, Olsen P, King GL 1989 Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes 38:123-129
8. Sumantran VN, Feldman EL 1993 Insulin-like growth factor I regulates c-myc and GAP-43 messenger ribonucleic acid expression in SH-SY5Y human neuroblastoma cells. Endocrinology 132:2017-2023
9. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
10. Villaudy J, Delbé J, Blat C, Desauty G, Goldé A, Harel L 1991 An IGF binding protein is an inhibitor of FGF stimulation. J Cell Physiol 149:492-496
11. Cohen P, Lamson G, Okajima T, Rosenfeld RG 1993 Tranfection of the human insulin-like growth factor binding protein-3 gene into balb/c fibroblasts inhibits cellular growth. Mol Endocrinol 7:380-386
12. Booth BA, Bar RS, Roes M, Dake BL, Bayne D, Cascieri M 1990 Intrinsic bioactivity of insulin-like growth factor-binding proteins from vascular endothelial cells. Endocrinology 127:2630-2638
13. Oh Y, Müller HL, Lamson G, Ronsenfeld RG 1993 Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chem 268:14964-14971
14. Singh P, Dai BS, Dhruva B, Widen SG 1994 Episomal expression of sense and antisense insulin-like growth factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I. Cancer Res 54:6563-6570
15. Andress DL, Birnbaum RS 1992 Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 267:22467-22472
16. Buckbinder L, Talbott R, Velascomiguel S, Takenaka I, Faha B, Seizinger BR, Kley N 1995 Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649
17. Bernardini S, Cianfarani S, Spagnoli A, Annicchiarico-Petruzzelli M, Melino G, Massoud R, Boscherini B, Finazzi-Agro A, Rosenfeld RG, Federici G 1994 Expression and down-regulation by retinoic acid of IGF Binding Protein-2 and -4 in medium from human neuroblastoma cells. J Neuroendocrinol 6:409-413
18. Babajko S, Binoux M 1996 Modulation of IGF and IGFBP expression by retinoic acid in human SK-N-SH neuroblastoma cells. Eur J Endocrinol 134:635-641
19. Ocrant I, Fay CT, Parmelee JT 1990 Characterization of insulin-like growth factor binding proteins produced in the rat central nervous system. Endocrinology 127:1260-1267
20. Ishikawa K, Ohe Y, Tatemoto K 1995 Synthesis and secretion of insulin-like growth factor binding protein-2 by cultured brain meningeal cells. Brain Res 697:122-129
21. Roghani M, Hossenlopp P, Lepage P, Balland A, Binoux M 1989 Isolation from human cerebrospinal fluid of a new insulin-like growth factor binding protein with a selective affinity for IGF-II. FEBS Lett 255:253-258
22. Binoux M, Lalou C, Lassarre C, Segovia B Regulation of IGF bioavailability by IGFBP proteases. In: Baxter RC, Gluckman PD, Rosenfeld RG (eds) The Insulin-Like Growth Factors and Their Regulatory Proteins. Program of the 3rd International Symposium on IGFs, Elsevier, 1994, pp 217-226
23. Gockerman A, Clemmons DR 1995 Porcine aortic smooth muscle cells secete a serine protease for insulin-like growth factor binding protein-2. Circ Res 76:514-521
24. Binoux M, Seurin D, Lassarre C, Gourmelen M 1984 Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF binding proteins (IGFBPs) produced by rat liver in culture. Estimation of serum IGFBP levels. J Clin Endocrinol Metab 59:453-462
25. Lalou C, Silve C, Rosato R, Segovia B, Binoux M 1994 Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF binding protein-3 production and proteolysis in human osteosarcoma cells. Endocrinology 135:2318-2326
26. Angelloz-Nicoud P, Binoux M 1995 Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology 136:5485-5492
27. Valinsky JE, Le Douarin NM 1985 Production of plasminogen activator by migrating cephalic neural crest cells. EMBO J 4:1403-1406
28. Danø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L 1985 Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-266
29. Neuman T, Stephens RW, Salonen E-M, Timmusk T, Vaheri A 1989 Induction of morphological differentiation of human neuroblastoma cells is accompanied by induction of tissue-type plasminogen activator. J Neurosci Res 23:274-281
30. Bulens F, Ibanez-Tallon I, Van Acker P, De Vriese A, Nelles L, Belayew A, Collen D 1995 Retinoic acid induction of human tissue-type plasminogen activator gene expression via a direct repeat element (DR5) located at -7 kilobases. J Biol Chem 270:7167-7175
31. Lund LR, Riccio A, Andreasen PA, Nielsen LS, Kristensen P, Laiho M, Saksela O, Blasi F, Danø K 1987 Transforming growth factor-β is a strong and fast acting positive regulator of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J 6:1286-1291
32. Guo Y-S, Townsend CM, Jin G-F, Beauchamp RD, Thompson JC 1995 Differential regulation by TGF-β1 and insulin of insulin-like growth factor binding protein-2 in IEC-6 cells. Am J Physiol 268:E1199-E1204
33. Biedler JL, Helson L, Spengler BA 1973 Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652
34. Ross RA, Spengler BA, Biedler JL 1983 Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 71:741-749
35. Mosmann T 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
36. Hossenlopp P, Seurin D, Segovia-Quison B, Hardouin S, Binoux M 1986 Analysis of serum insulin-like growth factor binding proteins using Western ligand blotting: use of the method for titration of the binding protein and competitive binding studies. Anal Biochem 154:138-143
37. Babajko S, Hardouin S, Segovia B, Groyer A, Binoux M 1993 Expression of insulin-like growth factor binding protein-1 and -2 genes through the perinatal period in the rat. Endocrinology 132:2586-2592
38. Maniatis T, Fritsch EF, Sambrook J 1982 Extraction, purification, and analysis of mRNA from eukaryotic cells. In: Molecular Cloning, a Laboratory Manual. Cold Spring Harbor Laboratory, pp 188-209
39. Binkert C, Landwehr J, Mary J-L, Schwander J, Heinrich G 1989 Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2). EMBO J 8:2497-2502
40. Loskutoff DJ, Sawdey M, Mimuro J 1989 Type 1 plasminogen activator inhibitor. In: Coller B (ed) Progress in Hemostasis and Thrombosis. Bermedica Production, Columbia, MD, vol 9:87-115
41. Laiho M, Keski-Oja J 1989 Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res 49:2533-2553
42. Saksela O, Rifkin DB 1988 Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 4:93-126
43. Thiele CJ, Reynolds CP, Israel MA 1985 Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 313:404-406
44. Knabbe C, Lippman ME, Wakefieldd LM, Flanders KC, Kasid A, Derynck R, Dickson RB 1987 Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428